Key Dates
Related Announcements
November 18, 2024 - Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional). See NOFO PAR-25-111.
Issued by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Purpose
The purpose of this Notice is to inform applicants that Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD) is extending the expiration date for PAR-25-111, Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) by one Application Due Date.
Therefore, with the addition/extension by one Application Due Date, PAR-25-111 now expires on July 07, 2026.
The following sections in Part 1. Overview Information, Key Dates section have been changed:
Currently reads:
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| February 16, 2025 * | March 16, 2025 * | Not Applicable | July 2025 | October 2025 | December 2025 |
| June 16, 2025 * | July 16, 2025 * | Not Applicable | November 2025 | January 2026 | April 2026 |
| October 16, 2025 * | November 16, 2025 * | Not Applicable | March 2026 | May 2026 | July 2026 |
| February 16, 2026 * | March 16, 2026 * | Not Applicable | July 2026 | October 2026 | December 2026 |
Expiration Date: May 08, 2026
Modified to read (in bold italics):
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| February 16, 2025 * | March 16, 2025 * | Not Applicable | July 2025 | October 2025 | December 2025 |
| June 16, 2025 * | July 16, 2025 * | Not Applicable | November 2025 | January 2026 | April 2026 |
| October 16, 2025 * | November 16, 2025 * | Not Applicable | March 2026 | May 2026 | July 2026 |
| February 16, 2026 * | March 16, 2026 * | Not Applicable | July 2026 | October 2026 | December 2026 |
| July 06, 2026 * | July 06, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
Expiration Date: July 07, 2026
All other aspects of PAR-25-111 remain unchanged.
Inquiries
Please direct all inquiries to:
Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Email: [email protected]
and Human Services (HHS)
